Internal Medicine, Infectious Disease · Brooksville, FL
NPI
1336131481
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
15435 Cortez Blvd
Brooksville, FL, 34613
Phone (352) 799-2294
Groups this clinician bills Medicare through
Medicare paid, 2024
$963K
996,503 services
Medicare patients, 2024
173
Average age 73
Drug cost, 2024
$1.1M
886 prescriptions
Company payments, 2025
$525
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vatsala S Sastry was code J0878 (injection, daptomycin, 1 mg), 762,151 times for 52 patients. In total Vatsala S Sastry billed 996,503 services in 22 codes, and Medicare paid $963K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 762,151 | 52 | $0.05 | $35K |
| J0121 Injection, omadacycline, 1 mg | Office | 166,802 | 54 | $2.97 | $496K |
| J2185 Injection, meropenem, 100 mg | Office | 16,021 | 20 | $0.29 | $4,655 |
| J3095 Injection, telavancin, 10 mg | Office | 11,700 | 24 | $5.47 | $64K |
| J2248 Injection, micafungin sodium, 1 mg | Office | 10,900 | 15 | $0.50 | $5,411 |
| J0692 Injection, cefepime hydrochloride, 500 mg | Office | 8,717 | 52 | $1.00 | $8,686 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 6,970 | 36 | $0.36 | $2,521 |
| 96365 Intravenous Infusion, Hydration | Office | 4,123 | 81 | $46.65 | $192K |
| 96367 Intravenous Infusion, Hydration | Office | 4,103 | 81 | $21.15 | $87K |
| 99232 Hospital E&M - Subsequent | Facility | 809 | 111 | $59.02 | $48K |
| 99222 Hospital E&M - Initial | Facility | 92 | 84 | $90.06 | $8,285 |
| 99233 Hospital E&M - Subsequent | Facility | 42 | 22 | $90.78 | $3,813 |
| 99223 Hospital E&M - Initial | Facility | 39 | 35 | $131.56 | $5,131 |
By year: 2022 $674K for 2,066,778 services; 2023 $837K for 2,322,988 services; 2024 $963K for 996,503 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vatsala S Sastry prescribed most often to Medicare patients was Doxycycline Hyclate, with 188 prescriptions and refills. In total Vatsala S Sastry wrote 886 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 188 | 188 | 90 | $3,767 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 171 | 173 | 20 | $730K |
| Cefdinir Generic | 129 | 129 | 57 | $6,861 |
| Vancomycin Hcl Generic | 35 | 35 | Under 11 | $6,303 |
| Fluconazole Generic | 33 | 33 | 21 | $857 |
| Rifampin Generic | 27 | 27 | 20 | $517 |
| Linezolid Generic | 27 | 27 | 15 | $6,051 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 17 | 17 | Under 11 | $68K |
| Levofloxacin-D5w Levofloxacin In Dextrose 5 % | 15 | 15 | Under 11 | $802 |
| Micafungin Micafungin Sodium | 15 | 15 | Under 11 | $4,129 |
| Azithromycin Generic | 14 | 14 | Under 11 | $283 |
| Cefepime Hcl Generic | 13 | 13 | Under 11 | $2,855 |
| Dovato Dolutegravir Sodium/Lamivudine | 13 | 13 | Under 11 | $37K |
| Levofloxacin Generic | 13 | 13 | Under 11 | $86.76 |
| Isentress Raltegravir Potassium | 12 | 12 | Under 11 | $27K |
Brand drugs: 267 claims; generic drugs: 619 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vatsala S Sastry $525 ($525 in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $170.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.